City councils
AbbVie's Patent Thicket: A Test of Sherman Act's Section 2
AbbVie, a pharmaceutical company, owns the patent for Humira, one of the world's best-selling and most profitable drugs. The company has obtained 132 additional patents related to the medicine, which expire in 2034. Welfare-benefit plans that pay for Humira on behalf of covered beneficiaries have sued AbbVie, arguing